Giovanni Squadrito

Prof. Dr. Giovanni Squadrito

University of Messina (Italy)
orcid

Research Focus & Metrics

Academic Career Length

25Years (2002-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 May 2008 in Journal of Hepatology
Verified
Journal Article
Closed access
GRGiovanni Raimondo
Giovanni Raimondo
GNGiuseppe Navarra
Giuseppe Navarra
Stefania MondelloStefania Mondello
Stefania Mondello
LCLucy Costantino
Lucy Costantino
GCGuido Colloredo
Guido Colloredo
TPTeresa Pollicino
Teresa Pollicino

Verified
Journal Article
Open access
PDF file
AGAnnalisa Giandalia
Annalisa Giandalia
Alfio GiuffridaAlfio Giuffrida
Alfio Giuffrida
Guido GembilloGuido Gembillo
Guido Gembillo
DCDomenico Cucinotta
Domenico Cucinotta
Giovanni SquadritoGiovanni Squadrito
Giovanni Squadrito
Giuseppina Tiziana RussoGiuseppina Tiziana Russo
Giuseppina Tiziana Russo
Diabetic kidney disease (DKD) is one of the most serious complications of both type 1 (T1DM) and type 2 diabetes mellitus (T2DM). Current guidelines recommend a personalized approach in order to reduce the burden of DM and its complications. Recognizing sex and gender- differences in medicine is considered one of the first steps toward personalized medicine, but the gender issue in DM has been scarcely explored so far. Gender differences have been reported in the incidence and the prevalence of DKD, in its phenotypes and clinical manifestations, as well as in several risk factors, with a different impact in the two genders. Hormonal factors, especially estrogen loss, play a significant role in explaining these differences. Additionally, the impact of sex chromosomes as well as the influence of gene–sex interactions with several susceptibility genes for DKD have been investigated. In spite of the increasing evidence that sex and gender should be included in the evaluation of DKD, several open issues remain uncovered, including the potentially different effects of newly recommended drugs, such as SGLT2i and GLP1Ras. This narrative review explored current evidence on sex/gender differences in DKD, taking into account hormonal, genetic and clinical factors.

1 October 2013 in Journal of Hepatology
Verified
Journal Article
Closed access
Giovanni SquadritoGiovanni Squadrito
Giovanni Squadrito
Irene CacciolaIrene Cacciola
Irene Cacciola
AAAngela Alibrandi
Angela Alibrandi
TPTeresa Pollicino
Teresa Pollicino
GRGiovanni Raimondo
Giovanni Raimondo

29 October 2021 in Pharmaceuticals
Verified
Journal Article
Open access
PDF file
MGMariarosaria Galeano
Mariarosaria Galeano
Giovanni PallioGiovanni Pallio
Giovanni Pallio
NINatasha Irrera
Natasha Irrera
FMFederica Mannino
Federica Mannino
Alessandra BittoAlessandra Bitto
Alessandra Bitto
FSFrancesco Squadrito
Francesco Squadrito
The normal wound healing process is characterized by a complex, highly integrated cascade of events, requiring the interactions of many cell types, including inflammatory cells, fibroblasts, keratinocytes and endothelial cells, as well as the involvement of growth factors and enzymes. However, several diseases such as diabetes, thermal injury and ischemia could lead to an impaired wound healing process characterized by wound hypoxia, high levels of oxygen radicals, reduced angiogenesis, decreased collagen synthesis and organization. Polydeoxyribonucleotide (PDRN) has been used to improve wound healing through local and systemic administration thanks to its ability to promote cell migration and growth, angiogenesis, and to reduce inflammation on impaired wound healing models in vitro, in vivo and clinical studies. In light of all these observations, the aim of this review is to provide a full overview of PDRN applications on skin regeneration. We reviewed papers published in the last 25 years on PubMed, inserting “polydeoxyribonucleotide and wound healing” as the main search term. All data obtained proved the ability of PDRN in promoting physiological tissue repair through adenosine A2A receptor activation and salvage pathway suggesting that PDRN has proven encouraging results in terms of healing time, wound regeneration and absence of side effects.

6 May 2024 in Metabolites
Verified
Journal Article
Open access
PDF file
CMCarmela Morace
Carmela Morace
GLGiuseppe Lorello
Giuseppe Lorello
FBFederica Bellone
Federica Bellone
CQCristina Quartarone
Cristina Quartarone
DRDomenica Ruggeri
Domenica Ruggeri
Herbert Ryan MariniHerbert Ryan Marini
Herbert Ryan Marini
An acute metabolic complication of diabetes mellitus, especially type 1, is diabetic ketoacidosis (DKA), which is due to an increase in blood ketone concentrations. Sodium/glucose co-transporter-2 inhibitor (SGLT2-i) drugs have been associated with the occurrence of a particular type of DKA defined as euglycemic (euDKA), characterized by glycemic levels below 300 mg/dL. A fair number of euDKA cases in SGLT2-i-treated patients have been described, especially in the last few years when there has been a significant increased use of these drugs. This form of euDKA is particularly insidious because of its latent onset, associated with unspecific symptomatology, until it evolves (progressing) to severe systemic forms. In addition, its atypical presentation can delay diagnosis and treatment. However, the risk of euDKA associated with SGLT2-i drugs remains relatively low, but it is essential to promptly diagnose and manage it to prevent its serious life-threatening complications. In this narrative review, we intended to gather current research evidence on SGLT2i-associated euDKA from randomized controlled trials and real-world evidence studies, its diagnostic criteria and precipitating factors.

31 January 2025 in Nutrients
Verified
Journal Article
Open access
PDF file
ATArianna Toscano
Arianna Toscano
FBFederica Bellone
Federica Bellone
NMNoemi Maggio
Noemi Maggio
MCMaria Cinquegrani
Maria Cinquegrani
FSFrancesca Spadaro
Francesca Spadaro
CMCarmela Morace
Carmela Morace
Background: Sepsis is a critical condition characterized by severe immune dysregulation, ranking among the leading causes of morbidity and mortality in intensive care and internal medicine units. Nutritional status plays a pivotal role in modulating these responses, as when inadequate it can compromise immune defenses, the body’s ability to handle stress and inflammation, and the clinical course. Malnutrition is frequently observed in septic patients and is strongly associated with worse clinical outcomes, including increased mortality, prolonged hospital stays, and greater complication rates. In this context, nutritional scoring systems have emerged as valuable tools to evaluate patients’ nutritional status and predict clinical trajectories. Objectives: Given the absence of a direct comparison of their performance in an internal medicine setting, this study aimed to assess the effectiveness of various nutritional scores as predictive tools for clinical outcomes in septic patients, emphasizing their application within the field of internal medicine. Methods and Results: A retrospective analysis was conducted on 143 patients diagnosed with sepsis or septic shock who were admitted to an internal medicine unit. Key variables included clinical and laboratory parameters, comorbidities, and nutritional scores at the time of diagnosis. The modified Glasgow Prognostic Score (mGPS), the Prognostic Nutritional Index (PNI), the Controlling Nutritional Status (CONUT) score, the modified Nutrition Risk in Critically Ill (mNUTRIC) score, and the blood urea nitrogen-to-albumin ratio (BAR) were evaluated in forecasting mortality and clinical outcomes in patients with sepsis. Among them, the mNUTRIC score emerged as the strongest independent predictor of in-hospital mortality, with a good performance and a reasonable threshold for risk stratification. Conclusions: The study highlights the mNUTRIC score’s practicality and reliability in assessing nutritional and inflammatory risks in septic patients, particularly in non-ICU settings. These findings suggest its potential utility in guiding nutritional interventions and improving clinical outcomes, emphasizing the importance of integrating nutritional assessment into sepsis management.